When should the starting dose of a Phosphodiesterase 5 (PDE5) inhibitor be lowered, in a patient taking Indinavir, Fluconazole, Warfarin, Doxycycline, or Tacrolimus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

The starting dose of a PDE5 inhibitor should be lowered in a patient taking indinavir (option A). Indinavir is a protease inhibitor used in HIV treatment that strongly inhibits CYP3A4, the primary enzyme responsible for metabolizing PDE5 inhibitors like sildenafil, tadalafil, and vardenafil, as discussed in 1. This inhibition leads to significantly increased plasma concentrations of PDE5 inhibitors, potentially causing dangerous side effects such as severe hypotension, priapism, and visual disturbances.

The mechanism of this interaction is based on the role of CYP3A4 in metabolizing PDE5 inhibitors. When CYP3A4 is inhibited by indinavir, the metabolism of PDE5 inhibitors is reduced, leading to increased plasma concentrations and a higher risk of adverse effects. This is a critical consideration in patients with underlying cardiovascular disease, as the combination of indinavir and PDE5 inhibitors can lead to potentially life-threatening hypotension, as noted in 2.

For patients on indinavir, the recommended starting dose of sildenafil should be reduced to 25 mg (instead of the usual 50 mg), tadalafil to 5 mg (instead of 10 mg), and vardenafil to 2.5 mg (instead of 10 mg), as a precautionary measure to minimize the risk of adverse effects. Additionally, patients should be monitored closely for adverse effects, and the frequency of PDE5 inhibitor use should be limited.

Key points to consider in the management of patients taking indinavir and PDE5 inhibitors include:

  • Close monitoring for adverse effects such as hypotension, priapism, and visual disturbances
  • Reduced starting doses of PDE5 inhibitors to minimize the risk of adverse effects
  • Limited frequency of PDE5 inhibitor use to reduce the risk of cumulative toxicity
  • Consideration of alternative treatments for erectile dysfunction that do not interact with indinavir, as discussed in 3 and 4.

Overall, the use of PDE5 inhibitors in patients taking indinavir requires careful consideration of the potential risks and benefits, and close monitoring to minimize the risk of adverse effects, as highlighted in 5.

Related Questions

Is it unsafe for a patient with hypertension to be prescribed two PDE‑5 inhibitors—Cialis (tadalafil) and daily tadalafil—concurrently?
What is the relationship between Phosphodiesterase 5 (PDE5) inhibitors and QTc (corrected QT) interval prolongation?
Are there any contraindications with tadalafil (Cialis) and fenofibrate (Fenfibraye)?
What are the known drug interactions between kratom and phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil, vardenafil, avanafil) used for erectile dysfunction?
Are there any contraindications with taking Tadalafil (Cialis) and Diltiazem (Cardizem)?
Does rectal prolapse cause rectal bleeding?
What germline mutation is associated with an increased incidence of early-onset high-grade prostate cancer: BRCA1 (Breast Cancer Gene 1), BRCA2 (Breast Cancer Gene 2), HOXB13 (Homeobox B13), TP53 (Tumor Protein P53), or MSH2 (MutS Homolog 2)?
Is furosemide (Lasix) still administered in cases of anuria (Impaired renal function)?
What is the diagnosis and treatment for stenosis of the flexor pollicis longus (FPL) tendon?
What are the indications for chest tube suction versus water seal (Water Seal) in thoracic drainage management?
What are the implications of a patient with leukocytosis (White Blood Cell count of 118), taking 8 tablets of aspirin (acetylsalicylic acid) 325mg daily for over a year, with a negative watergate (likely referring to a water test or possibly a reference to a specific medical test, but assuming it refers to a negative result on a test for anemia or other condition) and anemia (implied by the mention of RBC, Red Blood Cells)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.